R&D Portfolio Managment

Phase III Go / No-Go Decision

Launch & Pricing Decision

Pricing & Reimbursement Negotiations

Competitive Adjustment

COMMERCIAL ASSESSMENT

VALUE PROPOSITION DEVELOPMENT

PRICING & MARKET ACCESS STRATEGY

PRICING & REIMBURSEMENT IMPLEMENTATION TOOLS

PRICING & MARKET ACCESS RE-EVALUALION

-Early pricing evaluation -Valuation & licensing -Market assessment

- Global pricing & reimbursement research - Reimbursement pathway analysis

-Pricing & reimbursement dossiers -Global pricing policy

- Pricing & access research - Lifecycle management

VALUE BASED PRICING - AN INTEGRATED APPROACH

Disease burden Met & unmet need Cost benefit & effectiveness QALY Societal costs Payer & provider perceptions Advocacy Pharma-political climate Price visibility & sensitivity

IDENTIFYING AND MEASURING VALUE DRIVERS
ANALYTICA'S TRIANGULATION METHODOLOGY

	Willness-to-Pay/Prescribe/Co-Pay
Product Performance		Reference Products

Integrating Clinical, Economic, and Humanistics Drivers Required
from Multiple Perspectives for the Optimal Value Proposition